VMP 39695111000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-codaprin 8mg/400mg dispersible tablets
BNF code 0407010M0AAABAB
Virtual Therapeutic Moiety Co-codaprin
Date identifier became valid 26 May 2021
Previous product identifier 322310004
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-codaprin 8/400 dispersible tablets
Basis of previous name BAN - British Approved Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products not Available
Non-availability status date 9 Mar 2020
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Codeine phosphate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 8.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Aspirin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 400.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Dispersible tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 5 (CD Inv)
Virtual Medicinal Product Packs
Co-codaprin 8mg/400mg dispersible tablets 100 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback